2006
DOI: 10.1016/j.humpath.2006.03.003
|View full text |Cite
|
Sign up to set email alerts
|

Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

3
55
1

Year Published

2007
2007
2017
2017

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 69 publications
(59 citation statements)
references
References 36 publications
(74 reference statements)
3
55
1
Order By: Relevance
“…Furthermore, eIF6 is known to interact with integrin-b4. 36 Deregulation of the WNT signalling is well described in ovarian serous adenocarcinoma pathogenesis, [37][38][39][40] indicating that eIF6 may have multiple biological roles in ovarian serous adenocarcinoma tumorigenesis.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, eIF6 is known to interact with integrin-b4. 36 Deregulation of the WNT signalling is well described in ovarian serous adenocarcinoma pathogenesis, [37][38][39][40] indicating that eIF6 may have multiple biological roles in ovarian serous adenocarcinoma tumorigenesis.…”
Section: Discussionmentioning
confidence: 99%
“…N-cadherin has been detected in benign and borderline tumors [51] as well as malignant effusions [52]. Moderate N-cadherin staining of serous and endometroid tumors has been reported, with mucinous and clear cell tumors demonstrating low or undetectable expression [18,[53][54][55]. To date, no relationship between N-cadherin positivity and tumor stage or metastasis has been established [53].…”
Section: B Cadherin Expression In Eocmentioning
confidence: 99%
“…Although control of E-cadherin expression in EOC has not been studied extensively, examples of mechanisms detected in other tumor types have been identified. Somatic mutations in the E-cadherin gene are rare in ovarian carcinomas [56], but activating mutations of β-catenin are detected in one histologic subtype of ovarian carcinoma, ovarian endometrioid adenocarcinoma [5,55,67,68]. Methylation of the E-cadherin promoter has been detected in epithelial ovarian neoplasms and associated with reduced E-cadherin protein [69][70][71].…”
mentioning
confidence: 99%
“…Aberrant redistribution of p120 has been observed in several epithelial malignancies, including gastric cancer (Jawhari et al, 1999;Karatzas et al, 1999;Karayiannakis et al, 1999;Thoreson and Reynolds, 2002;Mayerle et al, 2003). Typically found at low levels in the nuclei of normal cells, increased levels of p120 have been observed in nuclei of tumor cells (Mayerle et al, 2003;Wijnhoven et al, 2005;Sarrio et al, 2006), and recent evidence has revealed that nuclear p120 acts to relieve transcriptional repression mediated by Kaiso, a member of the broad complex, tramtrak, bric a brac/pox virus, and zinc finger family (BTB/POZ) (Daniel and Reynolds, 1999). The Kaiso/p120 complex can modulate noncanonical Wnt signaling (Kim et al, 2004), and, along with T cell factor (TCF)/ ␤-catenin complexes, coordinately regulate canonical Wnt gene targets such as cyclin D1 and mmp-7 (Park et al, 2005;Spring et al, 2005), both of which are up-regulated by H. pylori (Hirata et al, 2001;Bebb et al, 2003;Crawford et al, 2003;Wroblewski et al, 2003;Chang et al, 2006).…”
mentioning
confidence: 99%